AI Buyer Insights:

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

ANI Pharmaceuticals Data, Technology Stack, and Enterprise Applications
Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2017 2017
CyberSecurity
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Cisco Systems Legacy Cisco Umbrella Secure Web Gateways (SWG) CyberSecurity n/a 2022 2022
In 2022, ANI Pharmaceuticals implemented Cisco Umbrella as its Secure Web Gateways (SWG) solution to strengthen DNS layer protection across its IT environment. The deployment was led from the company site in Baudette, MN and was driven by an internal recognition of security and management gaps that required rapid tooling and policy work. Cisco Umbrella was implemented specifically for DNS protection, with deployment activities focused on DNS layer enforcement and web filtering capabilities common to Secure Web Gateways (SWG). The implementation narrative records the use of Cisco Umbrella DNS protection as the primary SWG signal, aligned with standard category functions such as domain level blocking, threat intelligence ingestion, and policy-based content controls. The Umbrella deployment was executed alongside other security and operational initiatives including Microsoft 365 Multi Factor Authentication and an Arctic Wolf security deployment, while NinjaOne was implemented for endpoint management. Operational workstreams concurrently included Windows server management activities, migration of file servers to newer operating systems, domain controller replacements, VMware host management, and HP SAN management, indicating coordination across IT operations and security teams. Governance and rollout were driven by project management from a senior IT analyst role, and included development of information security policy to institutionalize controls introduced by Cisco Umbrella and companion tools. The implementation is described as part of a broader effort to address identified security and management gaps, with responsibility and ongoing management falling to ANI Pharmaceuticals IT and security operations.
IT Decision Makers and Key Stakeholders at ANI Pharmaceuticals
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by ANI Pharmaceuticals Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD ANI Pharmaceuticals Technographics

ANI Pharmaceuticals is a Life Sciences organization based in United States, with around 642 employees and annual revenues of $486.0 million.

ANI Pharmaceuticals operates a diverse technology stack with applications such as Microsoft 365 and Cisco Umbrella, covering areas like Collaboration and Secure Web Gateways (SWG).

ANI Pharmaceuticals has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Microsoft and Cisco Systems.

ANI Pharmaceuticals recently adopted applications including Cisco Umbrella in 2022 and Microsoft 365 in 2017, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of ANI Pharmaceuticals’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates ANI Pharmaceuticals’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete ANI Pharmaceuticals technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.